One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine

Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior. By Noah Weiland from NYT Health https://ift.tt/2MPPRZi